20 completed. 20 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 20 | Completed 20 |
| Phase 2 | 4 | Completed 4 |
Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants ART5803, Intravenous immunoglobulin (IVIG) - Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody, Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder) | Phase 1 | Completed | Arialys Therapeutics | 7 | 2025-02-25 | 2026-04-27 |
| A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease | Phase 1 / Phase 2 | Completed | SK Bioscience Co., Ltd. | 161 | 2025-02-24 | 2026-09-11 |
| Phase 1 Study of ART5803 in Healthy Participants ART5803 - Autoimmune Encephalitis | Phase 1 | Completed | Arialys Therapeutics | 64 | 2024-09-19 | 2026-04-27 |
| Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects MVA-BN-WEV Dose 1, MVA-BN-WEV Dose 2, MVA-BN-WEV Dose 3 - Equine Encephalitis | Phase 1 | Completed | Bavarian Nordic | 45 | 2019-10-07 | 2020-08-20 |
| VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2019-04-02 | 2021-03-24 |
| IL-2 in Refractory Autoimmune Encephalitis Proleukin - Encephalitis | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 10 | 2016-03-01 | 2021-09-29 |
| Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis Stem cell transplantation - Encephalitis, Meningitis | Phase 1 / Phase 2 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 22 | 2014-06-16 | 2024-06-06 |
| Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Completed | Ichor Medical Systems Incorporated | 42 | 2013-12-01 | 2015-08-26 |
| Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71 INV21 Low Dose, INV21 High Dose, Placebo - Hand, Foot and Mouth Disease | Phase 1 | Completed | Inviragen Inc. | 36 | 2011-08-01 | 2015-05-06 |
| Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults WN/DEN4delta30 vaccine, Placebo - West Nile Fever | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 26 | 2008-03-01 | 2013-01-03 |
| Phase Ib Study of SC Milatuzumab in SLE milatuzumab, Placebo - Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid | Phase 1 | Completed | Gilead Sciences | 22 | 2007-01-01 | 2021-08-19 |
| Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid AVI-4065 Injection - Encephalitis | Phase 1 | Completed | Sarepta Therapeutics, Inc. | 12 | 2006-09-01 | 2009-07-08 |
| Phase I Study of West Nile Virus Vaccine VRC-WNVDNA020-00-VP - West Nile Fever | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2006-03-03 | 2017-07-02 |
| Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults LGT(TP21)/DEN4, Placebo - Tick-Borne Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 28 | 2005-07-01 | 2008-01-21 |
| Vaccine to Prevent West Nile Virus Disease VRC-WNVDNA017-00-VP - Healthy, West Nile Fever | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2005-03-22 | 2017-07-02 |
| Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults WN/DEN4-3'delta30, Placebo - West Nile Fever Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 56 | 2005-02-01 | 2013-01-03 |
| A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis Rituximab - Chronic Focal Encephalitis, Rasmussen's Encephalitis | Phase 1 | Completed | California Pacific Medical Center Research Institute | 10 | 2005-01-01 | 2013-03-22 |
| IVIG - West Nile Encephalitis: Safety and Efficacy Omr-lgG-am, Polygam® S/D, Placebo - West Nile Virus | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 62 | 2003-09-01 | 2011-02-07 |
| A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients Pyrimethamine, Leucovorin calcium, Zidovudine - Toxoplasmosis, Cerebral, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 26 | 2021-11-04 | |
| A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS Azithromycin, Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections | Phase 1 | Completed | Pfizer | 45 | 2008-08-26 |
West Nile Fever (4) · Autoimmune Diseases of the Nervous System (2) · Encephalomyelitis, Venezuelan Equine (2) · HIV Infections (2) · Toxoplasmosis (2) · Toxoplasmosis, Cerebral (2) · Acquired Immunodeficiency Syndrome (1) · Alphavirus Infections (1) · Encephalitis, Japanese (1) · Encephalitis, Tick-Borne (1) · Encephalomyelitis, Eastern Equine (1) · Encephalomyelitis, Equine (1) · Encephalomyelitis, Western Equine (1) · Enterovirus Infections (1)
Brain Diseases (20) · Central Nervous System Diseases (20) · Nervous System Diseases (20) · Neuroinflammatory Diseases (20) · Infections (15) · Central Nervous System Infections (13) · RNA Virus Infections (13) · Virus Diseases (12) · Central Nervous System Viral Diseases (10) · Arbovirus Infections (9) · Encephalitis, Arbovirus (9) · Encephalitis, Viral (9) · Infectious Encephalitis (9) · Vector Borne Diseases (9)
Leucovorin (2) · Pyrimethamine (2) · Azithromycin (1) · Immunoglobulins, Intravenous (1) · Rituximab (1) · Saline Solution (1) · Stem Cell Transplantation (1) · Zidovudine (1) · aldesleukin (1) · aluminum sulfate (1) · milatuzumab (1)
National Institute of Allergy and Infectious Diseases (NIAID) (8) · Arialys Therapeutics (2) · Bavarian Nordic (1) · California Pacific Medical Center Research Institute (1) · Gilead Sciences (1) · Ichor Medical Systems Incorporated (1) · Inviragen Inc. (1) · Pfizer (1) · SK Bioscience Co., Ltd. (1) · Sarepta Therapeutics, Inc. (1) · Seoul National University Hospital (1) · Vinmec Research Institute of Stem Cell and Gene Technology (1)
United States (14) · Australia (3) · Canada (1) · New Zealand (1) · Singapore (1) · Vietnam (1)
Anna Durbin, MD (2) · Sankalp Gokhale, MD, MBA (2) · Anna Durbin, M.D. (1) · B Luft (1) · Carlos Fierro, MD (1) · Grace Chen, MD (1) · Julie E Ledgerwood, DO (1) · Kenneth D Laxer, M.D. (1) · Liem T Nguyen (1) · Luft B (1) · Paul A Tambyah, MBBS (1) · Paula M Shaw, MD (1) · Peter Wright, MD (1) · Remington J (1) · William Wegener, PhD, MD (1)
PMID 18190252, PMID 21398392, PMID 27206386, PMID 28296863, PMID 28403842, PMID 35568049, PMID 38494412